NDC product
Ondansetron
NDC 17856-0672 · Atlantic Biologics Corp.
Key facts
| Product NDC | 17856-0672 |
|---|---|
| Proprietary name | Ondansetron |
| Nonproprietary name | Ondansetron Hydrochloride |
| Substances | ONDANSETRON HYDROCHLORIDE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Atlantic Biologics Corp. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA078776 |
| Pharmacologic classes | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| Marketing start | Nov 28, 2007 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: